Westfield Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-84,352
Closed -$28.6M 254
2021
Q2
$28.6M Buy
84,352
+4,406
+6% +$1.5M 0.17% 156
2021
Q1
$32.3M Buy
79,946
+61,451
+332% +$24.9M 0.2% 145
2020
Q4
$12.3M Buy
+18,495
New +$12.3M 0.07% 187